This work is licensed under a Creative Commons Attribution 4.0 International License.
Current Thoracic Surgery
2018 , Vol 3 , Issue 1
Current surgical management of extrapulmonary oligometastatic non-small cell lung carcinoma
1Thoracic Surgery and Lung Transplantation Clinic, Turkiye Yuksek Ihtisas Training and Research Hospital, Ankara, Turkey
DOI :
10.26663/cts.2018.0007
Viewed :
7321
-
Downloaded :
2261
Lung cancer is one of the leading cause of mortality around the world, and it is widely known that
survival is limited in metastatic lung carcinoma cases. However, in oligometastatic, non-small cell lung
carcinoma cases, surgical excision of both the primary tumor and the metastatic site may yield a survival
advantage in selected cases. In non-small cell lung carcinoma cases, especially after metastasectomy of
brain and adrenal gland metastasis, studies in which survival advantage is reported are common in the
literature, and metastasectomy is the treatment method applied to selected patient groups in brain and
adrenal gland metastases. In surgical treatment of extra-cranial and extra-adrenal oligometastasis, on the
other hand, there are several cases in which morbidity-free survival rates were reported after successful
management. In this report, the surgical treatment results were evaluated, and the contribution of
treatment methods to survival rates were investigated in extrapulmonary oligometastatic non-small cell
lung carcinoma cases receiving surgical excision.
Keywords :
extrapulmonary, oligometastasis, lung cancer, brain, adrenal gland, non-small cell